Evaluating the effectiveness of a sodium cromoglycate group drug in the treatment of allergic conjunctivitis

• Main Authors: S. Sh. Mirrakhimova, K. I. Narzikulova, J. O. Safarov
• Format: Article
• Language: Russian
• Published: Real Time Ltd 2020-05-01
• Series: Российский офтальмологический журнал
• Subjects: allergic conjunctivitis; mast cell membrane stabilizers; sodium cromoglycate; allergic edema; follicles
• Online Access: https://roj.igb.ru/jour/article/view/424

Purpose. To study the effectiveness and tolerability of sodium cromoglycate (Uzbekistan) in the treatment of allergic conjunctivitis. Material and methods. 60 patients (120 eyes) with allergic conjunctivitis aged 18 to 60 years (28 men and 32 women), were divided into two homogeneous groups with similar clinical manifestations. The main group (30 patients), in addition to basic treatment, received instillations of sodium cromoglycate, 2 drops 4 times a day for 4 weeks. The control group (30 patients) received a foreign medication of the same group, instilled in the same way. Results. The patients of both groups revealed a comparable therapeutic effect. By the end of the treatment course, substantial positive changes were observed and the symptoms of allergic inflammation disappeared. The treatment effectiveness was 95.9 and 97.6 % in the main and the control groups, respectively. Conclusion. The use of domestic medication of the sodium cromoglycate group reduces the patients’ subjective complaints and helps achieve a maximum therapeutic effect at a price affordable by the patient and the clinic. No side effects or cases of intolerance to the drug of sodium cromoglycate group used have been revealed.